GLYC GlycoMimetics, Inc.

0  -2%
Previous Close 4.58
Open 4.60
Price To book 3.02
Market Cap 105.21M
Shares 23,329,000
Volume 34,835
Short Ratio 13.14
Av. Daily Volume 42,039

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 enrollment of first arm completed - March 7, 2017. Completion of enrollment in second arm due mid-2017. Data updates due at ASCO June 5, 2017. Abstract 2520.
Acute myeloid leukemia (AML) newly diagnosed and refractory - cancer
Phase 3 initiated June 2015. Enrollment to be completed 2H 2018.
GMI-1070 (rivipansel)
Vaso-occlusive crisis of sickle cell disease

Latest News

  1. GlycoMimetics to Present New AML Clinical Data at ASCO 2017 Annual Meeting
  2. ETFs with exposure to GlycoMimetics, Inc. : April 5, 2017
  3. GlycoMimetics, Inc. :GLYC-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
  4. GlycoMimetics Appoints Scott Koenig of MacroGenics to Board of Directors
  5. GlycoMimetics Completes Enrollment of Newly Diagnosed AML Patient Cohort in Phase 2 Clinical Trial of GMI-1271
  6. GlycoMimetics to Present New Preclinical Data in Multiple Myeloma at AACR Annual Meeting 2017
  7. GlycoMimetics reports 4Q loss
  8. GlycoMimetics Reports Fourth Quarter and Year-End 2016 Results
  9. Pharma company executives debate drug pricing increases
  10. How Dawson Geophysical Company (DWSN) Stacks Up Against Its Peers
  11. GlycoMimetics Announces Publication of Preclinical Data Showing Drug Candidate GMI-1271 Reduces Inflammatory Responses After Heart Attack
  12. GlycoMimetics Initiated At Outperform By Cowen And Company
  13. GlycoMimetics to Present at Canaccord Genuity 36th Annual Growth Conference
  14. featured highlights: GlycoMimetics, Lion Biotechnologies, AMN Healthcare Services, Gibraltar Industries and Coherent
  15. GlycoMimetics Reports Second Quarter 2016 Results
  16. New Strong Buy Stocks for July 7th
  17. GlycoMimetics Doses First Patient in Phase 2 Portion of Clinical Trial of GMI-1271 in Newly Diagnosed Acute Myeloid Leukemia